Their combination may cause immunogenic cell death and relieve immunosuppressive components in PC microenvironment, including increased tumor infiltration of CD8+ T cells and B+ cells (63), which well indicated that this combination exerted a synergistic effect to enhance the therapeutic efficacy of patients. This evidence concerns the gene CD8A and neoplasm.